Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer

BACKGROUND: Evidence for the efficacy of immunotherapy in biliary tract cancer (BTC) is limited and unsatisfactory. METHODS: Chinese BTC patients receiving a PD-1 inhibitor with chemotherapy, PD-1 inhibitor monotherapy or chemotherapy alone were retrospectively analyzed. The primary outcome was over...

詳細記述

保存先:
書誌詳細
出版年:Cancer Immunol Immunother
主要な著者: Sun, Danyang, Ma, Junxun, Wang, Jinliang, Han, Chun, Qian, Yuanyu, Chen, Guangying, Li, Xiaoyan, Zhang, Juan, Cui, Pengfei, Du, Wushuang, Wu, Zhaozhen, Chen, Shixue, Zheng, Xuan, Yue, Zhichao, Song, Jia, Gao, Chan, Zhao, Xiaochen, Cai, Shangli, Hu, Yi
フォーマット: Artigo
言語:Inglês
出版事項: Springer Berlin Heidelberg 2019
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6768892/
https://ncbi.nlm.nih.gov/pubmed/31535160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02386-w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料